Insider Transactions in Q4 2023 at Harrow Health, Inc. (HROW)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 16
2023
|
Mark L Baum CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
7,500
+0.37%
|
$60,000
$8.11 P/Share
|
|
Nov 15
2023
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
25,000
+0.68%
|
$200,000
$8.03 P/Share
|
|
Nov 10
2023
|
John P. Saharek CEO of ImprimisRx |
SELL
Payment of exercise price or tax liability
|
Direct |
9,778
-4.04%
|
$117,336
$12.83 P/Share
|
|
Nov 10
2023
|
John P. Saharek CEO of ImprimisRx |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+7.63%
|
-
|